Clinical trial
Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness
NCT07356986 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness
- Lead sponsor
- Oregon Health and Science University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 31, 2026
- Completion date
- December 31, 2027
- Enrollment
- 50 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
gestational diabetes, postpartum